NAMPT and glioblastoma: Pharmacological inhibition of NAMPT by FK866 was previously shown to sensitize immune cells to the alkylating agent 1-methyl-3-nitro-1-nitrosoguanidine (MNNG)41 and glioblastoma cells to the alkylating agent temozolomide42,43.